# Azithromycin in Bronchiolitis Obliterans Syndrome

> **NCT01009619** · PHASE4 · COMPLETED · sponsor: **KU Leuven** · enrollment: 83 (actual)

## Conditions studied

- Bronchiolitis Obliterans Syndrome
- Graft Rejection
- Lymphocytic Bronchiolitis
- Respiratory Infection

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01009619
- **Lead sponsor:** KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2011-10-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01009619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01009619, "Azithromycin in Bronchiolitis Obliterans Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01009619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*